# K170624: TalarLift STS

- Pathway: 510(k) (Traditional)
- Applicant: Fusion Orthopedics, LLC
- Decided: Aug 11, 2017 after 162 days
- Product code: HWC (Screw, Fixation, Bone)
- Device class: 2
- Regulation: 21 CFR 888.3040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K792670 (1980). 11 ancestors in all.
No later device cites it as a predicate yet.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K093055: CSTS Screw, Orthopro, LLC (2010) Summary page 4.
- K032682: STS Screw, Ortho-Pro, LLC (2003) Summary page 4.
- K142534: HyProCure II, Graham Medical Technologies, LLC Dba Gramedica (2014) Summary page 4.
- K041289: Talus of Vilex (Tov), Vilex, Inc. (2004) Summary page 4.
- K080280: Sub-Talar Lok, Model 7-11 MM, Instratek, Inc. (2008) Summary page 4.

## Indications for use
The TalarLift STS arthroereisis implant is designed for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block the posterior and inferior displacement of the talus, allowing normal subtalar joint motion while blocking excessive pronation and the resulting sequelae. The TalarLift STS is intended for the following pathological conditions resulting from disease, injury, or other trauma: *Hypermobile pes valgus; *Posterior tibial tendon dysfunction; *Severe pronation; *Subtalar instability; *Hypermobile flexible congenital flat foot.

Source page: https://510kreport.com/device/K170624
Methodology: https://510kreport.com/methodology